drugset / Trial / NCT00333112

A Study to Evaluate Solifenacin Succinate in Combination With Tamsulosin for the Treatment of Residual Overactive Bladder Symptoms (OAB) in Men.

NCT00333112

Phase 4 Completed 398 enrolled Astellas Pharma Inc
RandomizedParallel-groupDouble-blindTreatment

Summary

A study to evaluate solifenacin succinate in combination with tamsulosin for the treatment of residual OAB symptoms in men.

Timeline

Start
2006-05
Primary completion
2007-01
Completion
2007-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Solifenacin Small molecule Oral
Background Tamsulosin Other / unclassified Oral

Indications